Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding

NCT02750501 is registered in ClinicalTrials.gov with Alcresta Therapeutics, Inc. as lead sponsor.

NCT NCT02750501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02750501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding
Lead sponsor
Alcresta Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2016
Completion date
March 30, 2017
Enrollment
49 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis